cholecalciferol 200,000 IU
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University Hospital, Angers
Overview
cholecalciferol 200,000 IU is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
cholecalciferol 200,000 IU clinical trials
Explore related
Medical disclaimer. This page summarizes research about cholecalciferol 200,000 IU for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.